Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 4,148 | 823 | 609 | 439 | 679 |
| Cost of Goods | 1,441 | 748 | 475 | 351 | 645 |
| Gross Profit | 2,707 | 75 | 134 | 88 | 34 |
| Operating Expenses | 2,414 | 2,736 | 2,316 | 3,035 | 2,426 |
| Operating Income | 734 | -1,913 | -1,707 | -2,596 | -1,747 |
| Interest Expense | 11 | 2 | 4 | 1,324 | 1,391 |
| Other Income | -20 | -56 | 110 | -579 | -39 |
| Pre-tax Income | 703 | -1,971 | -1,601 | -4,499 | -3,177 |
| Net Income Continuous | 703 | -1,971 | -1,601 | -4,499 | -3,177 |
| Net Income | $703 | $-1,971 | $-1,601 | $-4,499 | $-3,177 |
| EPS Basic Total Ops | 0.07 | -0.28 | -0.24 | -0.80 | -0.68 |
| EPS Basic Continuous Ops | 0.10 | -0.28 | -0.24 | -0.81 | -0.68 |
| EPS Diluted Total Ops | 0.10 | -0.28 | -0.24 | -0.80 | -0.68 |
| EPS Diluted Continuous Ops | 0.07 | -0.28 | -0.24 | -0.81 | -0.68 |
| EBITDA(a) | $901 | $-1,750 | $-1,543 | $-2,427 | $-1,605 |